Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2018 1
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic.
Mazzitelli M, Gregori D, Sasset L, Trevenzoli M, Scaglione V, Lo Menzo S, Marinello S, Mengato D, Venturini F, Tiberio I, Navalesi P, Cattelan A. Mazzitelli M, et al. Among authors: lo menzo s. Microorganisms. 2023 Apr 10;11(4):984. doi: 10.3390/microorganisms11040984. Microorganisms. 2023. PMID: 37110408 Free PMC article.
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes.
Longato E, Morieri ML, Sparacino G, Di Camillo B, Cattelan A, Lo Menzo S, Trevenzoli M, Vianello A, Guarnieri G, Lionello F, Avogaro A, Fioretto P, Vettor R, Fadini GP. Longato E, et al. Among authors: lo menzo s. Comput Methods Programs Biomed. 2022 Jun;221:106873. doi: 10.1016/j.cmpb.2022.106873. Epub 2022 May 11. Comput Methods Programs Biomed. 2022. PMID: 35588662 Free PMC article.
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study.
Mengato D, Mazzitelli M, Francavilla A, Bettio M, Sasset L, Presa N, Pivato L, Lo Menzo S, Trevenzoli M, Venturini F, Gregori D, Cattelan AM. Mengato D, et al. Among authors: lo menzo s. Clin Exp Med. 2023 Oct;23(6):2749-2756. doi: 10.1007/s10238-023-01036-x. Epub 2023 Mar 24. Clin Exp Med. 2023. PMID: 36961678 Free PMC article.
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study.
Mengato D, Mazzitelli M, Francavilla A, Bettio M, Sasset L, Presa N, Pivato L, Menzo SL, Trevenzoli M, Venturini F, Gregori D, Cattelan AM. Mengato D, et al. Among authors: menzo sl. Clin Exp Med. 2023 Oct;23(6):2757. doi: 10.1007/s10238-023-01088-z. Clin Exp Med. 2023. PMID: 37289236 Free PMC article. No abstract available.
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Iannetta M, Zingaropoli MA, Bellizzi A, Morreale M, Pontecorvo S, D'Abramo A, Oliva A, Anzivino E, Lo Menzo S, D'Agostino C, Mastroianni CM, Millefiorini E, Pietropaolo V, Francia A, Vullo V, Ciardi MR. Iannetta M, et al. Among authors: lo menzo s. PLoS One. 2016 Aug 3;11(8):e0160277. doi: 10.1371/journal.pone.0160277. eCollection 2016. PLoS One. 2016. PMID: 27486658 Free PMC article. Clinical Trial.
11 results